查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球脂溢性角化病 (SK) 治療市場：增長、未來展望、競爭分析 (2022-2030)
市場調查報告書
商品編碼
1184698

全球脂溢性角化病 (SK) 治療市場：增長、未來展望、競爭分析 (2022-2030)

Seborrheic Keratosis Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 115 Pages | 商品交期: 最快1-2個工作天內

價格

到 2026 年，全球脂溢性角化病 (SK) 治療市場預計將達到 13.208 億美元。

對化妝品和美容產品的偏好上升以及脂溢性角化病 (SK) 的高患病率是脂溢性角化病 (SK) 治療市場的主要驅動力。 預計脂溢性角化病 (SK) 治療市場的未來增長也將受到有希望的外用候選藥物在管線中的推動。

在本報告中，我們對全球脂溢性角化病 (SK) 治療市場進行了研究和分析，系統地包括市場趨勢、競爭分析、市場動態、細分市場和地區市場分析以及公司概況。我們提供信息。

內容

第一章前言

第 2 章執行摘要

第 3 章脂溢性角化病 (SK) 治療市場：競爭分析

  • 領先的脂溢性角化病 (SK) 治療市場供應商的市場定位
  • 脂溢性角化病 (SK) 治療市場供應商採用的策略
  • 主要行業戰略
  • 分層分析：2021 年與 2030 年

第 4 章脂溢性角化病 (SK) 治療市場：宏觀分析和市場動態

  • 簡介
  • 全球脂溢性角化病 (SK) 治療市場價值（2020-2030 年）
  • 市場動態
    • 市場驅動力
    • 市場製約因素
    • 主要問題
    • 重要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析

第 5 章脂溢性角化病 (SK) 治療市場：按治療類型分類 (2020-2030)

  • 市場概覽
  • 增長和收益分析：2021 年與 2030 年
  • 市場細分
    • 手術治療
    • 局部溶液治療
    • 管道藥物

第 6 章北美脂溢性角化病 (SK) 治療市場 (2020-2030)

  • 市場概覽
  • 按治療類型（2020-2030 年）
  • 按地區（2020-2030 年）
    • 北美

第 7 章。英國和歐盟脂溢性角化病 (SK) 治療市場 (2020-2030)

  • 市場概覽
  • 按治療類型（2020-2030 年）
  • 按地區（2020-2030 年）
    • 英國/歐盟

第 8 章亞太脂溢性角化病 (SK) 治療市場 (2020-2030)

  • 市場概覽
  • 按治療類型（2020-2030 年）
  • 按地區（2020-2030 年）
    • 亞太地區

第 9 章拉丁美洲脂溢性角化病 (SK) 治療市場 (2020-2030)

  • 市場概覽
  • 按治療類型（2020-2030 年）
  • 按地區（2020-2030 年）
    • 拉丁美洲

第 10 章中東和非洲脂溢性角化病 (SK) 治療市場 (2020-2030)

  • 市場概覽
  • 按治療類型（2020-2030 年）
  • 按地區（2020-2030 年）
    • 中東和非洲

第11章公司簡介

  • Aclaris Therapeutics, Inc.
  • Cortex Technology ApS
  • CryoConcepts LP
  • Cryoswiss GmbH
  • DRE Medical, Inc.
  • EpiPharm AG
  • H&O Equipments SA
  • Orasure Technologies, Inc.
  • Special Medical Technology Co., Ltd.
  • Wallach Surgical Devices, Inc.
Product Code: 138069-08-22

Market Excerpt

The global seborrheic keratosis (SK) treatment expected to reach US$ 1,320.8 Mn by 2026. Growing preference for cosmetic and aesthetic quotient and high prevalence of seborrheic keratosis are observed to be the key factors driving the seborrheic keratosis treatment market. This market is further characterized by the presence of a multitude of players operating in various treatment modules such as laser, cryosurgery, surgical removal etc. In addition, with promising topical candidates in the pipeline, the seborrheic keratosis treatment market will witness a boost in future growth.

According to an article published by Jackson JM et.al in 2015 (Jackson JM et.al. Current Understanding of Seborrheic Keratosis: Prevalence, Etiology, Clinical Presentation, Diagnosis, and Management, J Drugs Dermatol; 2015 Oct; 14(10):1119-25.), an estimated of 83 million people were affected by seborrheic keratosis in 2014 and dermatologists reported an average diagnosis of 155 patients per month with the disease in the United States. Of these patients, 33% had over 15 lesions and 67% had 15 or lesser lesions. In addition, with the surge in geriatric population, the eligible patient pool for SK treatment further expands, thus driving the overall market growth. Furthermore, it was estimated that around 43% of the patients opt for the surgical treatment due to benign and less painful nature of the growth. Additionally, lack of reimbursement policies in developed as well as developing countries for the treatment hinders the market growth. Reimbursement is considered for seborrheic keratosis treatment only in cases of bleeding, itching and other medical reasons, and not for cosmetic treatments. Manufacturers are investing in research and development for the non-invasive and non-surgical treatment methods for seborrheic keratosis. For instance, in 2017, a topical solution - Eskata, 40% hydrogen peroxide, was approved for the treatment.

"Approval of topical solutions will drive the market during the forecast period"

Several topical solutions are used as off-label therapeutics to reduce the height of the seborrheic keratosis including ammonium lactate and alpha hydroxy acids among others. However, in 2017, the FDA approved hydrogen peroxide (40% solution), branded as Eskata developed by Aclaris Therapeutics, Inc. for the treatment of seborrheic keratosis. The product will be available in the United States after its expected commercialization in the first half of 2018. A few other topical solutions are currently in pipeline, which are expected to be approved within the forecast period. Development of cost-effective and non-surgical treatment options are anticipated to drive the market coupled with the rising awareness in the patient population.

Cryosurgery is the most preferred treatment for seborrheic keratosis, followed by other surgical treatment options such as electrocautery, curettage etc. With the adoption of laser treatment methods, the market for seborrheic keratosis treatments will experience an upsurge. In 2021, cryosurgery segment led the market in terms of market value and will retain its lead during the forecast period. High preference by physicians due to significant treatment outcomes mainly contribute to the dominance of this segment. Demand for topical solution treatment (Eskata) as a viable treatment option in the market, after its commercialization in 2018, significantly contribute to the market growth.

"Asia Pacific to experience lucrative growth during the forecast period"

Asia Pacific is expected to experience the fastest market growth during the forecast period owing to growing prevalence of SK and increasing adoption of surgical treatment in the region. Since there is no clarity on commercialization of Eskata (40% hydrogen peroxide) in the region, other treatment segments in the region will not face any substantial competition. In 2021, North America dominated the global seborrheic keratosis market owing to the adoption of advanced treatment options and awareness of the disease. Additionally, a majority of the players are headquartered in the United States, which further contributes to the supremacy of North America. In terms of market value, North America was followed by Europe in 2021. In Europe, it has been estimated that over 90% of adults aged over 60 or more have at least one or more SK lesions. Approximately 40%-60% of the entire population in Europe has at least one SK lesion. Northern Europe has a higher prevalence of seborrheic keratosis.

"Cryosurgery devices are among the major revenue contributors to the manufacturers"

Although several options are available in the market for seborrheic keratosis treatment, cryosurgery is the most preferred treatment method due to proven better treatment outcomes. Preference as viable treatment method coupled with high prevalence resulted in growing installation of cryosurgery devices in the United States and other developed countries. Furthermore, players are investing in introduction of cost-effective and non-surgical treatment of the disease. For instance, EpiPharm AG, a Switzerland based company, is investing in new and non-invasive therapies for the treatment of benign skin tumors. EPI-SK14, pipeline product, of EpiPharm is in Phase II clinical trials and is a non-invasive treatment for seborrheic keratosis. Furthermore, manufacturers have diverse product portfolio, which satisfies the growing demand of the disease burden.

This report further describes the major qualitative assessment factors including key market trends, market drivers & restraints, to aid in better understanding of global seborrheic keratosis treatment market. Furthermore, the key players are graphically mapped based on their product offering, market strategies and business strength. The report also provides attractive investment proposition based on the extensive geographical research. Key players profiled in the report include Aclaris Therapeutics, Inc., Cortex Technology ApS, CryoConcepts LP, Cryoswiss GmbH, EpiPharm AG, H&O Equipments SA, Orasure Technologies, Inc., Special Medical Technology Co., Ltd., and Wallach Surgical Devices, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Seborrheic Keratosis Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Seborrheic Keratosis Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Treatment Type

Surgical Treatment

Cryosurgery

Electrocautery

Curettage

Laser Ablation

Topical Solution Treatment

Hydrogen Peroxide 40% Solution (Eskata)

Pipeline Drugs (Qualitative Information)

EPI SK14 (EpiPharm AG)

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of Covid-19 Segment (2020-2021; US$ Million )

Pre Covid-19 situation

Post Covid-19 situation

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Seborrheic Keratosis Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Seborrheic Keratosis Treatment market?

Which is the largest regional market for Seborrheic Keratosis Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Seborrheic Keratosis Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Seborrheic Keratosis Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Seborrheic Keratosis Treatment Market
  • 2.2. Global Seborrheic Keratosis Treatment Market, By Treatment Type, 2021 (US$ Million)
  • 2.3. Global Seborrheic Keratosis Treatment Market, By Geography, 2021 (US$ Million)
  • 2.4. Attractive Investment Proposition by Geography, 2021

3. Seborrheic Keratosis Treatment Market: Competitive Analysis

  • 3.1. Market Positioning of Key Seborrheic Keratosis Treatment Market Vendors
  • 3.2. Strategies Adopted by Seborrheic Keratosis Treatment Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Seborrheic Keratosis Treatment Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Seborrheic Keratosis Treatment Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Surgical Treatment
      • 5.3.1.1. Cryosurgery
      • 5.3.1.2. Electrocautery
      • 5.3.1.3. Curettage
      • 5.3.1.4. Laser Ablation
    • 5.3.2. Topical Solution Treatment
      • 5.3.2.1. Hydrogen Peroxide 40% Solution (Eskata)
    • 5.3.3. Pipeline Drugs (Qualitative Information)
      • 5.3.3.1. EPI SK14 (EpiPharm AG)

6. North America Seborrheic Keratosis Treatment Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
  • 6.3.Seborrheic Keratosis Treatment Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.North America
      • 6.3.1.1. U.S.
        • 6.3.1.1.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 6.3.1.2. Canada
        • 6.3.1.2.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 6.3.1.3. Rest of North America
        • 6.3.1.3.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)

7. UK and European Union Seborrheic Keratosis Treatment Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
  • 7.3.Seborrheic Keratosis Treatment Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.UK and European Union
      • 7.3.1.1. UK
        • 7.3.1.1.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 7.3.1.2. Germany
        • 7.3.1.2.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 7.3.1.3. Spain
        • 7.3.1.3.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 7.3.1.4. Italy
        • 7.3.1.4.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 7.3.1.5. France
        • 7.3.1.5.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 7.3.1.6. Rest of Europe
        • 7.3.1.6.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)

8. Asia Pacific Seborrheic Keratosis Treatment Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
  • 8.3.Seborrheic Keratosis Treatment Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Asia Pacific
      • 8.3.1.1. China
        • 8.3.1.1.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 8.3.1.2. Japan
        • 8.3.1.2.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 8.3.1.3. India
        • 8.3.1.3.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 8.3.1.4. Australia
        • 8.3.1.4.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 8.3.1.5. South Korea
        • 8.3.1.5.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 8.3.1.6. Rest of Asia Pacific
        • 8.3.1.6.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)

9. Latin America Seborrheic Keratosis Treatment Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
  • 9.3.Seborrheic Keratosis Treatment Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Latin America
      • 9.3.1.1. Brazil
        • 9.3.1.1.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 9.3.1.2. Mexico
        • 9.3.1.2.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 9.3.1.3. Rest of Latin America
        • 9.3.1.3.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)

10. Middle East and Africa Seborrheic Keratosis Treatment Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
  • 10.3.Seborrheic Keratosis Treatment Market: By Region, 2020-2030, USD (Million)
    • 10.3.1.Middle East and Africa
      • 10.3.1.1. GCC
        • 10.3.1.1.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 10.3.1.2. Africa
        • 10.3.1.2.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)
      • 10.3.1.3. Rest of Middle East and Africa
        • 10.3.1.3.1. Seborrheic Keratosis Treatment Market: By Treatment Type, 2020-2030, USD (Million)

11. Company Profile

  • 11.1. Aclaris Therapeutics, Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Cortex Technology ApS
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. CryoConcepts LP
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Cryoswiss GmbH
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. DRE Medical, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. EpiPharm AG
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. H&O Equipments SA
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Orasure Technologies, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. Special Medical Technology Co., Ltd.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Wallach Surgical Devices, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 2 Global Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 3 Global Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 4 Global Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 5 North America Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 6 North America Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 7 North America Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 8 North America Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 9 U.S. Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 10 U.S. Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 11 U.S. Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 12 U.S. Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 13 Canada Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 14 Canada Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 15 Canada Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 16 Canada Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 17 Rest of North America Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 18 Rest of North America Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 19 Rest of North America Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 20 Rest of North America Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 21 UK and European Union Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 22 UK and European Union Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 23 UK and European Union Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 24 UK and European Union Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 25 UK Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 26 UK Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 27 UK Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 28 UK Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 29 Germany Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 30 Germany Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 31 Germany Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 32 Germany Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 33 Spain Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 34 Spain Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 35 Spain Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 36 Spain Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 37 Italy Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 38 Italy Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 39 Italy Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 40 Italy Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 41 France Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 42 France Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 43 France Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 44 France Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 45 Rest of Europe Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 46 Rest of Europe Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 47 Rest of Europe Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 48 Rest of Europe Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 49 Asia Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 50 Asia Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 51 Asia Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 52 Asia Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 53 China Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 54 China Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 55 China Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 56 China Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 57 Japan Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 58 Japan Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 59 Japan Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 60 Japan Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 61 India Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 62 India Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 63 India Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 64 India Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 65 Australia Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 66 Australia Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 67 Australia Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 68 Australia Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 69 South Korea Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 70 South Korea Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 71 South Korea Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 72 South Korea Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 73 Latin America Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 74 Latin America Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 75 Latin America Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 76 Latin America Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 77 Brazil Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 78 Brazil Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 79 Brazil Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 80 Brazil Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 81 Mexico Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 82 Mexico Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 83 Mexico Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 84 Mexico Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 85 Rest of Latin America Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 86 Rest of Latin America Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 87 Rest of Latin America Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 88 Rest of Latin America Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 89 Middle East and Africa Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 90 Middle East and Africa Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 91 Middle East and Africa Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 92 Middle East and Africa Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 93 GCC Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 94 GCC Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 95 GCC Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 96 GCC Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 97 Africa Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 98 Africa Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 99 Africa Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 100 Africa Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Seborrheic Keratosis Treatment Market By Treatment Type, 2020-2030, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Seborrheic Keratosis Treatment Market By Surgical Treatment, 2020-2030, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Seborrheic Keratosis Treatment Market By Topical Solution Treatment, 2020-2030, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Seborrheic Keratosis Treatment Market By Pipeline Drugs (Qualitative Information), 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Seborrheic Keratosis Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Seborrheic Keratosis Treatment Market: Quality Assurance
  • FIG. 5 Global Seborrheic Keratosis Treatment Market, By Treatment Type, 2021
  • FIG. 6 Global Seborrheic Keratosis Treatment Market, By Geography, 2021
  • FIG. 7 Market Geographical Opportunity Matrix - Global Seborrheic Keratosis Treatment Market, 2021
  • FIG. 8 Market Positioning of Key Seborrheic Keratosis Treatment Market Players, 2021
  • FIG. 9 Global Seborrheic Keratosis Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 10 Global Seborrheic Keratosis Treatment Market, By Treatment Type, 2021 Vs 2030, %
  • FIG. 11 U.S. Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 12 Canada Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 13 Rest of North America Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 14 UK Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 15 Germany Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 16 Spain Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 17 Italy Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 18 France Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 19 Rest of Europe Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 20 China Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 21 Japan Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 22 India Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 23 Australia Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 24 South Korea Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Asia Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 26 Brazil Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 27 Mexico Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Latin America Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 29 GCC Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 30 Africa Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030
  • FIG. 31 Rest of Middle East and Africa Seborrheic Keratosis Treatment Market (US$ Million), 2020 - 2030